Stay updated on TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a small update to the page's version history.
    Difference
    0.0%
    Check dated 2026-08-28T11:44:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Eligibility criteria text was refined by updating the ANC and bilirubin thresholds (removing and rewording prior criteria). A MedlinePlus Genetics reference was added under related topics to provide melanoma-related background information.
    Difference
    0.5%
    Check dated 2026-08-21T10:54:53.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Melanoma, the related topics header, and MedlinePlus Genetics were removed from the page's related topics section, reducing the topic labels shown with the study.
    Difference
    0.1%
    Check dated 2026-08-14T11:15:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new revision marker 'Revision: v3.6.5' was added. Several related topics items were removed, including 'Melanoma', 'related topics:', 'MedlinePlus Genetics', and the older revision 'Revision: v3.6.4'.
    Difference
    0.2%
    Check dated 2026-08-07T10:18:24.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added related topics to the page: Melanoma and MedlinePlus Genetics, enhancing topic connections and navigation.
    Difference
    0.1%
    Check dated 2026-07-31T10:37:52.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Footer shows a revision update from v3.6.3 to v3.6.4. This reflects a small maintenance update to the page without changing study content or functionality.
    Difference
    0.0%
    Check dated 2026-07-24T12:21:44.000Z thumbnail image

Stay in the know with updates to TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page.